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Zusammenfassung 
 
Hintergrund: 
Biologisches "Organ engineering" ist ein neues Verfahren um protentiell transplantierbare 
Organe zu generieren.  Dabei wird das Organ explantiert, dezellularisiert und anschließend 
repopuliert.  Bisher wurden zahlreiche Protokolle zur Dezellularisierung etabliert. Aktuell gibt 
es weitaus weniger Kenntnisse zur erfolgreichen Repopulation und lediglich präliminäre 
Berichte zur  Kurzzeitfunktion (maximal 72h) nach Transplantation einzelner repopulierter 
Leberlappen. Die Langzeitfunktion des transplantierten Lebergerüsts ist immer noch eine 
Zukunftsvision. Daher ist eine alternative zum Ex-vivo "Liver engineering"  erforderlich um 
die Bedingungen der funktionellen Repopulierung besser zu verstehen.  
Vor kurzem (2016) hat die Arbeitsgruppe von PAN über ihre Arbeiten zur  In-vivo-
Dezellularisierung und Repopulation des rechten unteren Lappens bei der Ratte berichtet. Alle 
Versuchstiere wurden jedoch nach  6 Stunden intraoperativer Beobachtungszeit getötet, da 
eine schwere Gewebeschädigung durch das Detergenz vermutet wurde.  
Ziel:  
Das Ziel dieser Studie ist die Entwicklung eines Überlebensmodells für die selektive in-vivo 
Dezellularisierung eines  Leberlappens im Rattenmodell.   
Methoden und Ergebnisse:  
Im der ersten Manuskript I  (Jove 2018, IF 1.3) haben  wir unser neues chirurgisches 
Modell der selektiven Perfusion des links-lateralen Leberlappens bei der Ratte vorgestellt. 
Der gewählte Leberlappen wurde für  entweder 20 min, 1h, 2h oder 4h (n=3/Gruppe) mit 
Heparin-Kochslazlösung gespült. Unabhängig von der Perfusionszeit wurde die Prozedure 
von allen tieren gut toleriert (Einwochenüberlebensrate von 100%, 12/12 Tieren). 
Histologisch fanden sich bereits nach 20min Perfusion keiebnrlie Blutzellen mehr im 
Gefäßsystem, Weder in der Portalven, noch in den Sinusoiden oder den Lebervenen.  
Im zweiten Manuskript II (eingereicht bei Acta Biomaterialia, IF 6.3) haben wir drei 
verschiedene Protokolle verglichen, um das optimale Verfahren für die In-vivo-
Dezellularisierung zu ermitteln. Wir beobachteten, dass bei zweistündiger Perfusion mit  1% 
SDS anstelle von 1% Triton X100 oder 1% Triton X100, gefolgt von 1% SDS die In-vivo-
Dezellularisierung des gewählten Leberlappens in etwa 2 Stunden reproduzierbar  zur 
histologisch vollständigen Entfernung aller  Zellkomponenten führte. 
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Die so generierten Lebergerüste wurde weiter charakterisiert.  Die Integrität der Gefäßstruktur 
einschließlich der Pfortader, der Leberarterie, des Gallengangs und der zentralen Vene sowie 
der Mikro- und Ultrastruktur der Matrix wurde durch CT, Histologie und SEM bestätigt. Wir 
konnten immunhistochemisch zeigen, daß die  Hauptmatrixproteine, einschließlich Collagen I 
und IV, Elastin, Fibronectin und Laminin, erhalten blieben, und wir somit ein qualitativ 
hochwertigs Lebergerüst generierten.   
Außerdem haben wir zwei Drainagemethoden verglichen, um die optimale Methode zur 
Organprotektion während der In-vivo-Dezellularisierung zu ermitteln. Mit Hilfe der  
kompletten  Abdeckung der Organe mit einem Polyvinylidenchlorid-Film  und  Kompressen 
bei gleichzeitiger Platzierung eines Absaugkatheters konnten wir eine 
Einwochenüberlebensrate von 100% erreichen (n=6/6), im Gegensatz zu nur 16,7% (n =1/6) 
ohne Verwedung des Absaugkatheters. 
Als letztes untersuchten wir die Interaktion zwischen Blut und dem Lebergerüst 12h nach 
Reperfusion. Zu diesem Zeitpunkt  fanden sich histologisch wie zu erwarten, nicht nur 
reichlich  Erythrozyten und Leukozyten in den großen Gefäßen und im sinusoidalen Netzwerk, 
sondern auch Thromben in den großen Gefäßen. 
Im letzen Schritt (Manuskript III in Vorbereitung) konnten wir in einem präliminären  
Experiment zeigen, daß durch eine lokale Heparinisierung die Thrombenbildung effizient 
verhindert wurde.  Die Tiere verstarben jedoch an lethalen Sickerblutungen aus der Basis des 
dezellularisierten Leberlappens, dort wo dieser zuvor abgeklemmt worden war. Vor 
Versuchen zur Repopulierung ist somit der nächste Schritt das beste Verfahren zur 
Verhinderung der Blutgerinnung im Lebergerüst zu finden, was das Blutungsrisiko nicht 
erhöht.  
Schlussfolgerungen:  
Der linkslateralen Leberlappens ist für die selektive in vivo Leberperfusion geeignet ist. In 
diesem Modell erwies sich 1%SDS als bestes Detergenz für die in-vivo Dezellularisierung.. 
Wir konnten zeigen, daß die  Bauchorgane erfolgreich durch die gezielte Abdeckung mit 
einem PVDC-Film und trockenen Kompressen sowie der Platzierung eines Absaugkatheters 
von SDS abgeschirmt und damit von einer korrosiven detergenzbedingten Schädigung 
bewahrt werden können.  Somit haben wir erfolgreich ein Überlebensmodell zur selektiven 
in-vivo Dezellularisation entwickelt.  
Vor Versuchen zur Repopulierung  ist der nächste Schritt das beste Verfahren zur 
Verhinderung der Blutgerinnung im Lebergerüst zu finden, was das Blutungsrisiko nicht 
erhöht.
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Summary 
 
Background:  
Recently biological liver engineering was proposed as a novel strategy to generate 
transplantable organs and is actively pursued worldwide. Liver engineering basically consists 
of generation of an acellular scaffold followed by repopulation of the scaffold. Most 
researchers focus on ex-vivo liver engineering. However, despite the development of 
numerous  protocols for decellularization, much less is known about successfully repopulating 
a scaffold. First, but rather preliminary reports were published describing selected in-vivo 
functions within a maximal observation time of 72h after transplanting the repopulated liver 
lobes. Long term function of a bioengineered full-size liver graft is still a vision of future. An 
alternative to ex-vivo liver engineering is needed to better understand functional repopulation. 
Recently, the research group of Pan (2016) reported in-vivo decellularization and 
recellularization on the right inferior lobe in rats. However, they sacrificed all experimental 
animals intraoperatively after an observation time of only 6 hours due to the suspected tissue 
injury caused by the detergent.  
Aim:  
The aim of this study is to generate a survival model of in-vivo selective liver lobe 
decellularization in rats. 
Methods and Results:  
As described in manuscript I (JOVE 2018, IF 1.3), prior to perform in-vivo 
decellularization, we generated an in-vivo selective liver lobe perfusion model using the left 
lateral lobe. The selected liver lobe was perfused with heparin saline for either 20 min, 1 h, 2 
h or 4 h respectively (n=3/group). Irrespectively of the perfusion time, the procedure was well 
tolerated by all animals (1w survival rate 100%, 12/12 animals). Histological assessment of 
the perfused lobe demonstrated the absence of blood cells in the portal vein branches, 
sinusoids and central vein branches already after 20min perfusion time, indicating successful 
generation of a circuit bypass through left lateral lobe in-vivo . 
As described in manuscript II (submitted to Acta Biomaterialia, IF 6.3), we compared 
three different protocols to identify the optimal protocol for in-vivo liver lobe 
decellularization. We observed that only using 2 hours of 1% SDS rather than 1% Triton 
X100 or 1% Triton X100 followed by 1% SDS resulted in the complete removal of cellular 
components as confirmed by histological assessment. We further characterized the scaffold 
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generated by the optimal protocol using 1% SDS. The integrity of the vascular structure 
including portal vein, hepatic artery, bile duct and central vein, as well as the micro- and 
ultrastructure of the matrix was confirmed by CT, histology and SEM, respectively. The main 
matrix proteins including collagen I and IV, elastin, fibronectin, and laminin were preserved 
as detected with strong signals in immunohistochemistry, altogether confirming the 
generation of a well-preserved high quality scaffold. 
Additionally, we compared two methods to drain the waste fluid. Covering the abdominal 
organs with polyvinylidene chloride (PVDC) film and dry gauze together with placing an 
aspiration tube resulted in complete protection from the corrosive detergent. All animals 
reached the designed observation time of one week (n=6/6), in contrast to only 16.7% (n=1/6) 
using the other drainage method with only PVDC film + dry gauze.   
Lastly, we further assessed the physiologically blood reperfusion of the scaffold. We found 
that blood cells but also some clots were visible in the portal vein, hepatic artery, sinusoids 
and central vein of the acellular scaffold confirmed by histological assessment 12 hours 
postoperatively. 
We achieved first preliminary results (manuscript III in preparation) regarding the next 
step towards in-vivo liver engineering, the prevention of coagulation within the scaffold upon 
blood reperfusion. Testing layer-by-layer heparinization confirmed the effectiveness, but 
revealed that lethal bleeding occurred unavoidably (n=6/6) at the base of the decellularized 
liver lobe where the clamp was placed. Our next step prior to repopulating the scaffold will be 
directed to identify the optimal coating preventing coagulation without increasing the risk of 
bleeding.   
Conclusions:  
We concluded that using the left lateral lobe as the targeted liver lobe for in-vivo selected 
liver perfusion is technically feasible. We also concluded that using 1% SDS as detergent was 
optimal for in-vivo perfusion decellularization of targeted liver lobe. We further identified 
that covering the abdominal organs with PVDC, gauze and placing a suction tube is the most 
efficient way to prevent corrosive injury of the abdominal organs. Finally, we concluded that 
the physiological reperfusion of the in-vivo scaffold is feasible. Altogether it lays a solid 
foundation for further studying in-vivo liver engineering. Here the next challenge prior to 
repopulation is to achieve the balance between prevention of coagulation without provoking 
bleeding.  
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Introduction  
 
Biological liver engineering is a new strategy to generate potentially transplantable liver 
grafts. Liver engineering consists of two steps: Generation of an acellular scaffold followed 
by repopulation. Liver scaffolds are usually generated by ex-vivo perfusion of the organ with 
biochemical detergents. The scaffolds are reseeded with either mature cells, hepatocellular as 
well as endothelial cell lines or mesenchymal stem cells. The three dimensional structure of 
the scaffold is available for cell adhesion, growth, differentiation, proliferation and migration, 
molecules signaling and promoting the expression of liver-specific functions.  
Most of researchers focus on ex-vivo liver engineering. However, in previous studies, 
partially repopulated scaffolds [Bao 2011 and Jiang 2014] or engineered full liver grafts 
[Uygun 2010, Kadota et al 2014, Ko et al 2015, Bruinsma 2015, Bao 2015 and Hussein 2016] 
were transplanted as an auxiliary heterotopic graft. The maximal reported survival time was 
limited to 72 hours [Bao 2011]. To our knowledge, orthotopic transplantation of a repopulated 
full liver graft has not yet been performed or published. Long term function and 
transplantation of engineered organs is still in its infancy. Therefore, an alternative approach 
to ex-vivo liver engineering is needed.  
The new concept of in-vivo organ-engineering emerged recently. This technique allows in-
vivo repopulated partial liver scaffold to be subjected to in-vivo physiological blood perfusion 
with the unique advantage of physiological “culture” conditions including the maintenance of 
proper temperature, sufficient supply of oxygen and nutrients and growth factors. Furthermore, 
hepatic function of the remaining normal liver principally allows long term survival of the 
animal. Therefore, in-vivo liver engineered tissue can potentially serve as an in-vivo three 
dimension “cell culture” model for hepatocyte proliferation and stem cell differentiation in 
comparison with ex-vivo. 
The group of Pan and colleagues were the first group to attempt in-vivo decellularization and 
repopulation using a rat model [Pan 2016]. They reported their novel technique of in-vivo 
decellularization of a single liver lobe followed by in-vivo repopulation using rat hepatocytes. 
However, the in-vivo surgical perfusion model of Pan has disadvantages. They achieved 
single liver lobe perfusion in rats at the expense of completely blocking the portal vein and 
inferior vena cava, which may cause severe harm to the animal. The experimental rats were 
sacrificed after only 6 hours of intraoperative observation time. They also claimed that the 
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short lifespan of the animals may be due to the injury caused by the detergent used. 
Postoperative survival has not yet been reported by now.  Therefore, the in-vivo liver lobe 
perfusion technique needs further improvement to achieve postoperative survival. No study 
was identified up to now which successfully circumvented this problem. Maintenance of 
hepatic blood flow requires preservation of blood flow through the vena cava and through 
branches of the portal vein during the procedure of selective in-vivo decellularization and 
recellularization. This is needed to maintain systemic blood circulation and the perfusion of 
the undecellularized liver lobe. Measures to prevent corrosive injury by the detergent are also 
needed.   
Therefore, despite substantially anatomic and technical challenges, we generated a survival 
model of in-vivo selective liver lobe decellularization based on our previous studies regarding  
hepatic anatomy of rat [Madrahimov 2006], portal vein cannulation technique for 
haemodynamic monitoring in mice [Xie 2014], and ex-vivo liver decellularization [Mussbach 
2016, Mussbach et al 2016].   
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Hypothesis 
 
Based on the described considerations we raise the following hypothesis: 
 The selective left lateral lobe is a suitable lobe for in-vivo liver lobe perfusion in rats 
due to its vascular anatomy. 
 Liver lobe decellularization in-vivo results in the complete removal of all cellular 
components within 2h. 
 Perfusion decellularization with 1% SDS results in the multiscale preservation of the 
hepatic architecture and in the preservation of the protein composition of the scaffold. 
 Complete protection of the abdominal organs from the corrosive detergent enables 
long term survival of the animals. 
 Physiologically reperfusion of an in-vivo intact decellularized liver lobe is feasible.  
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Aims 
 
We set five aims for this study: 
 To establish a novel surgical technique for in-vivo selective left lateral liver lobe 
perfusion in rat. 
 To identify the optimal protocol for in-vivo liver lobe perfusion decellularization. 
 To confirm the integrity of structural architecture of the scaffold generated with the 
optimal protocol. 
 To identify the optimal drainage method for in-vivo liver lobe perfusion 
decellularization. 
 To confirm the physiological reperfusion of the in-vivo biological scaffold.  
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Study Design 
 
In order to reach the aims we designed a study composed of two parts including five 
corresponding steps: 
      Part I                 Manuscript I 
 Establishment of a surgical technique for in-vivo perfusion only through the selective 
left lateral liver lobe in rat. 
Part II               Manuscript II 
 Comparison of three different detergents to identify the optimal protocol for in-vivo 
liver lobe decellularization in rat.  
 Characterization of the scaffold generated with the optimal detergent.  
 Comparison of two different drainage methods to identify the optimal drainage 
method for in-vivo liver lobe decellularization in rat.  
 Physiological reperfusion of the intact decellularized liver lobe. 
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Abstract:  
In-vivo liver decellularization has become a promising strategy to study in-vivo liver 
engineering. However, long term survival after in-vivo liver decellularization has not yet been 
achieved due to anatomical and technical challenges. This study aimed to establish a survival 
model of in-vivo partial liver lobe perfusion-decellularization in rat.  
We compared three decellularization protocols (1%Triton X100 followed by 1%SDS, 1%SDS 
versus 1%Triton X100, n=6/group). Using the optimal one as judged by macroscopy, 
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histology and DNA-content, we characterized the structural integrity and matrix-proteins 
using histology, scanning electron microscopy (SEM), Computed Tomography (CT) scanning 
and immunohistochemistry. We prevented contamination of the abdominal cavity with the 
corrosive detergents by using polyvinylidene chloride (PVDC) film + dry gauze in 
comparison to PVDC-film + dry gauze + aspiration tube (n=6/group). Physiological 
reperfusion was assessed by histology. Survival rate was determined after a 7 d observation 
period.  
Only perfusion with 1% SDS resulted in an acellular scaffold (fully translucent without 
histologically detectable tissue remnants, DNA concentration is less than 2% of that in native 
lobe) with remarkable structural and ultrastructural integrity as well as preservation of main 
matrix proteins (immunohistochemically positive for collagen IV, laminin, and elastin). 
Contamination of abdominal organs with the potentially toxic SDS-solution was achieved by 
placing a suction tube in addition to the PDVC-film + dry gauze and allowed 7d-survival of 
all animals without severe postoperative complications.  Upon reperfusion, the liver turned 
red within sec without any leakage from the surface of the liver. About 12 h after reperfusion, 
blood cells but also some clots were visible in the portal vein (PV), sinusoidal matrix network 
and central vein (CV), suggesting physiological perfusion.  
In conclusion, our results study shows the first available data on generation of a survival 
model of in-vivo parenchymal organ decellularization, creating a critical step towards in-vivo 
organ engineering.  
 
Keywords  
Perfusion decellularization in-vivo, Polyvinylidene chloride film, extracellular matrix, In-vivo 
liver engineering, In-vivo organ engineering 
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BD: Biliary duct.  
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IVC: Inferior vena cava,  
PVDC: Polyvinylidene chloride 
PV: Portal vein,  
RML: Right median lobe 
SDS:  Sodium dodecyl sulfate 
SEM:  Scanning electron microscope 
 
Impact Statement  
Recently in-vivo liver decellularization has been considered as a promising approach to study 
in-vivo liver repopulation of a scaffold over ex-vivo. However, long term survival of in-vivo 
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liver decellularization has not yet been achieved. Here, despite anatomical and technical 
challenges, we successfully created a survival model of in-vivo selected liver lobe 
decellularization in rat, providing a major step towards in-vivo organ engineering. 
 
Introduction  
Recently, decellularization using detergents has become an attractive technique widely used 
in studies of tissue engineering. This technique is applied to fabricate a biological non-
immunogenic acellular matrix, which can be used for further generation of an engineered 
tissue or organ. The potential applications of decellularized matrix followed by 
recellularization have been demonstrated for a variety of tissues, including trachea [1, 2], 
esophagus [3], bladder [4, 5], blood vessel [6-8], skin [9]  and cartilage [10] . However, only 
some ex-vivo engineered structural tissues e.g. cartilage [10], bladder [4] and skin [11] but not 
functional organs e.g. lungs, heart or livers, have already been clinically used to treat patients. 
Liver engineering has been emerging as a research hot spot around the world owing to the 
increasing demand of transplantable grafts for patients who need liver transplantation. 
However, researchers mainly study ex-vivo liver engineering [12-17]. Most of the 
transplantation studies used acellular or repopulated scaffolds for heterotopic transplantation 
to assess biocompatibility respectively selected functional aspects [18-22].  However, neither 
biliary duct (BD) nor hepatic artery (HA) was orthotopically anastomosized to the recipient. 
The maximally reported observation time was limited to 72 hours only [23, 24]. By far, 
orthotopic transplantation of an ex-vivo repopulated full liver graft has not yet been reported. 
Long term function and transplantation of engineered organs are still a vision. Therefore, 
looking for an alternative methodology to ex-vivo for studying liver engineering is needful 
[25].  
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Besides ex-vivo liver engineering, in-vivo liver engineering may represent a promising 
strategy to study hepatic repopulation under physiological conditions. The advantages of in-
vivo partial liver engineering compared to ex-vivo liver engineering are as follows:  Firstly, in 
contrast to ex-vivo perfusion with artificial culture medium, the in-vivo repopulated partial 
liver scaffold can receive physiological blood perfusion maintaining the organ at the 
physiological temperature, ensuring the needed amount of oxygen and growth factors [25]. 
Secondly, BD and HA are naturally preserved, in contrast to implantation of ex-vivo 
engineered liver lobes without anastomosis of either BD or HA as reported by other authors 
[20, 23, 26]. Last and most importantly, the remaining normal liver lobes maintain hepatic 
function allowing long term survival [25]. Pan and colleagues tried in-vivo decellularization 
and recellularization of the right inferior lobe in rat. However, all experimental animals were 
sacrificed after only 6 hours of intraoperative observation time in their trial. They claimed that 
the short lifespan of the animals may be due to the injury caused by the detergent used [27]. 
Postoperative survival has not yet been reported by now.  
Prior to in-vivo liver lobe engineering, survival after in-vivo perfusion decellularization of a 
selected liver lobe is a prerequisite. Three main challenges need to be addressed: (1) Owing to 
the complicated intrahepatic vascular anatomy, the first challenge is to properly isolate the 
selected liver lobe and generate a fluid circuit bypass only through the isolated lobe 
compromising portal perfusion or venous drainage of the non-selected liver lobes. (2) Since 
the maximal operation time for an in-vivo liver lobe perfusion should not exceed 5 h [25], the 
second challenge is to identify a time-efficient in-vivo decellularization protocol not 
exceeding 2 h. Doing so is the prerequisite for later reseeding and cell settlement which might 
take another 2 h, leading to a total procedure time of about 5 h for liver engineering. (3) To 
prevent intra-abdominal corrosive injury by the detergent, the third challenge is to cover all 
other organs and tissues and drain the waste fluid without any contamination of the abdominal 
cavity.  
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Therefore, to establish survival after in-vivo liver lobe perfusion decellularization, three 
critical subgoals need to be accomplished: one is to achieve perfusion of the targeted liver 
lobe without blocking the vena cava and the main PV for a long period. In our previous study, 
we already accomplished this goal [25]. Second is to limit the decellularization time to 2 h. 
Third is to prevent the animal from chemical injury owing to detergent contamination during 
in-vivo decellularization. 
To limit the decellularization duration, identifying a proper protocol for in-vivo 
decellularization which allows maintaining scaffold structure and preserving matrix proteins 
is critical. Detergents frequently used for ex-vivo liver decellularization include Triton X-100, 
SDS, or Triton combined with SDS [12-18, 24, 28-30]. The concentration of the Triton X-100 
solution used for organ perfusion ranges from 0.5% up to 3% and the SDS solution from 
0.01% to 1% [15, 20, 31-35]. Similarly, the decellularization time also ranges from hours up 
to several weeks [14, 19, 34, 35, 39, 40]. The flow rate employed in the protocols ranges from 
1 to 200ml/min, depending on the species [15, 16, 20, 36-38]. In our previous study on ex-
vivo liver decellularization in rodent, we used 1% SDS followed by 1% Triton as detergents 
for ex-vivo liver lobe decellularization in mouse and obtained an intact extracellular matrix 
within only 3 h of perfusion period [21]. To minimize the in-vivo decellularization duration  
to not more than 2 h, here we tried to compare three decellularization protocols of using the 
combination of 1% SDS followed by 1% Triton X100，1% Triton X100 only and 1% SDS 
only, to identify the ideal in-vivo partial liver lobe perfusion decellularization protocol in rat. 
To prevent chemical damage during in-vivo decellularization, looking for an efficient 
drainage method to prevent contamination of the abdominal organs with the detergent is also 
important. However, no report has been published about drainage optimization during in-vivo 
decellularization. Preventing detergent from leakage into the abdominal cavity resulting in 
damaging other organs is rather challenging due to the difficulty of isolating the uneven 
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surface of the abdominal cavity and other organs from the being decellularized lobe. 
Therefore, here we also tried to create a novel isolation and sufficient drainage method for in-
vivo partial liver lobe decellularization. 
In brief, in a previous study we achieved the establishment of selected liver lobe perfusion 
technique [25]. We here further compared three in-vivo liver lobe decellularization protocols 
and two drainage methods to identify the ideal partial liver decellularization protocol. The key 
steps for the procedure are illustrated in Figure 1. 
 
  
Material and Methods 
Animals 
In total, 43 male Lewis rats (aged at 11-13 weeks) were used (Table 1). All protocols were 
approved by The Thüringer Landesamt für Verbraucherschutz, Thuringia, Germany (Reg.No: 
UKJ-17-031) and conform to European guidelines on Care and Use of Laboratory Animals.  
Experimental Design 
The experiment was performed in three steps: (1) Small modifications of selective perfusion 
technique to adjust it for in-vivo decellularization (n=3). (2) Identification of optimal protocol 
for in-vivo selective liver lobe decellularization and characterization of the scaffold quality 
(n=25). (3) Prevention of contamination to abdominal cavity caused by the detergent (n=12) 
and histological assessment after postoperative 12 h for confirmation of short term 
physiological perfusion (n=3). 
Modification of selective perfusion technique to make it suitable for in-vivo 
decellularization 
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Prior to decellularization, the rats (n=3) underwent a surgical circuit bypass only through the 
LLL based on small modifications of the perfusion technique previously reported [25].  
In contrast to the previous study, where a suture ligation was used, here the left PV was 
blocked with micro-clamps (Fig 2A). This facilitated the insertion of the 24 G needle-free 
catheter as a fluid inlet. Using a second clamp, the left HA and the left BD as well as the left 
median PV, the left median HA and the left median BD were blocked. To speed up the 
procedure, we created the outlet (Fig 2B) in the left lateral HV by performing a small 1 mm 
long incision instead of using a catheter. Doing so facilitated the placement of the PDVC film 
and the dry gauze needed to protect the abdominal organs from the corrosive detergent 
solution during later in-vivo liver lobe decellularization. At the same time, detergent leaking 
from the surface of the organ could be absorbed. As a next step, selective perfusion of the 
LLL was started using 15 ml of heparinized saline (40 U/ml) at flow rate of 1 ml/min. Success 
of selective perfusion was judged based on the selective color change of LLL from fresh red 
to faint yellow as well as on a representative histological assessment, as reported before.  
Comparison of three detergents for in-vivo perfusion decellularization 
To identify the optimal protocol for in-vivo perfusion decellularization of the targeted LLL, 
we designed three experimental groups (n=6/group) for histological work-up. After heparin 
perfusion of the lobes using the modified perfusion technique, we compared perfusion of 
1%SDS for 1 h followed by 1 h of 1%Triton with perfusion of either 2 h of only 1%Triton X 
or 2 h of only 1%SDS respectively.   
Detergents were applied using a peristaltic pump (Harvard apparatus 70P, USA) (Fig. 3A), at 
a flow rate of 1.4 ml/min, 4 s interval, 1.8 ml/min for 2 hours. The abdominal cavity was 
protected from the contaminating detergent by covering all organs with PVDC film (Fig. 3B). 
Outflowing waste perfused fluid was drained using dry gauze (Fig. 3C). 
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Immediately after in-vivo perfusion decellularization, rats were sacrificed for assessment of 
decellularization efficiency based on macroscopic appearance of the liver lobe, histological 
assessment and DNA content. 
The most efficient decellularization protocol was used for further characterization of scaffold 
quality. Integrity of the portal vascular tree was examined using injection of blue silicone 
rubber compound via the left PV followed by micro-CT scanning (n=3 scaffolds, and 
additional one normal as control). Integrity of the matrix structure of vascular and biliary tree 
and the sinusoidal network was assessed by histomorphology. The ultrastructure was 
visualized using scanning electron microscopy (n=2 scaffolds, and additional one normal as 
control). Preservation of matrix proteins (elastin, fibronectin, laminin, and collagen IV) was 
assessed based on immunohistochemical staining.  
Comparison of two drainage methods to eliminate waste fluid during in-vivo perfusion 
decellularization 
To prevent the abdominal organs from direct contact with the detergent leading to corrosive 
injury, we further designed another two groups (n=6/group) based on two different drainage 
methods: PVDC film + dry gauze and PVDC film + dry gauze + aspiration tube. For the first 
group, the drainage method of using PVDC film + dry gauze was performed as described in 
the first experiment. For the second group, an aspiration tube (Fig. 3D) was placed close to 
the base of the LLL for further drainage. After having put everything in place, the lobe was 
decellularized using the most efficient decellularization protocol determined before. Constant 
liver perfusion was achieved by the Harvard peristaltic pump at the same flow rate and 
duration as mentioned above. Detergent leakage, drainage efficiency and especially one week 
survival rate were taken as indicators of the optimal drainage method for in-vivo perfusion 
decellularization. 
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Physiological blood reperfusion of the decellularized scaffold in-vivo 
After in-vivo perfusion decellularization of the LLL with the optimal detergent, the 
decellularized scaffold was flushed with 0.9% sodium chloride solution at a flow rate of 
5ml/min for 10 min to remove most of the residual SDS from the approximately 3 ml scaffold. 
The incisions of the left PV and left lateral hepatic vein were closed with 11-0 prolene sutures. 
All micro-clamps were taken off the vessels to allow physiological blood reperfusion of the 
decellularized lobe. Macroscopic change of the color of the scaffold from transparent to bright 
red was taken as an indicator to confirm the success of in-vivo physiological reperfusion. The 
abdominal cavity was washed with 50 ml warm 0.9% sodium chloride solution to remove any 
possible contaminating SDS leaking from the liver lobe during decellularization. After closing 
the abdominal cavity, all rats in both groups were allowed to recover from anesthesia. 
Buprenorphine was administered subcutaneously in a dose of 0.05 mg/kg twice per day, so as 
to relieve postoperative pain. Totally, 6 rats per drainage group were used for one week 
survival analysis. With the most efficient drainage method determined from the above two 
groups, histological assessment at 12 hours postoperatively was performed to confirm the 
physiological reperfusion of the decellularized scaffolds (additional 3 rats). 
Histological staining    
Liver sections of 3 µm thickness were cut after formalin fixation and paraffin embedding. 
Sections were stained with histochemical dyes for haematoxylin and eosin staining. The 
stained sections were scanned at x 40 magniﬁcation with the scanner NanoZoomer 2.0 HT 
using the software NDP scan (Hamamatsu, Japan) 
Verhoeff-Van Gieson staining (EvG staining) 
Histological sections were dewaxed at 59 ºC in a warming cabinet for 30 min and then 
dehydrated through a descending alcohol series including Xylol and Alcohol (100%, 96% and 
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70%). The sections were rinsed with distilled water 3 times, followed by incubation with 
resorcinafuchsin (00088663, Hollborn&Söhne) 120 min. Afterwards they were rinsed with 
96% alcohol until no more color clouds left, and again briefly washed with distilled water for 
3 times. Mayer´s hematoxylin (T865.3, Roth) was applied to stain the sections for 30 min. 
After being washed with distilled water 3 times, the sections were further stained with Van 
Gieson (Ch.-B.:0219, Apotheke) They were again washed with distilled water and dehydrated 
through an ascending alcohol series including alcohol (70%, 96% and 100%) and Xylol, and 
then coverslipped. The stained sections were scanned in the same way as described above. 
(Nuclei, black brown; Cytoplasm, light brown; Collagen, red). 
Digitalized images were used for the morphological analysis. First, we checked the H&E 
images from the scaffolds subjected to different decellularization protocols for the presence of 
remaining liver cells or cellular debris (nuclei, purple/black). Second, structural integrity 
(collagen, pink) was also assessed based on the H&E staining of scaffolds obtained after 1% 
SDS-only decellularization. We identified the key features of the hepatic acinus such as the 
portal field with the PV, HA and the BD as well as the CV based on the appearance of the 
matrix structure (collagen, pink). We than assessed the integrity of the sinusoidal matrix 
structure based on the continuity of the network. We further judged the optimal 
decellularization protocol based on EvG staining. 
Immunohistochemical staining 
To further assess matrix proteins of the scaffold, immunostaining was performed. Briefly, 
sample tissues were fixed 4% formaldehyde and then embedded with paraffin. Liver sections 
were cut into 3 µm thickness. A panel of primary rabbit antibodies were used for 
immunostaining: Anti-collagen IV (ab6586, 1:500, abcam), Anti-fibronectin (ab2413, 1:200, 
abcam), Anti-elastin (ab21610, 1:100, abcam) and Anti-laminin (ab11575, 1:1000, abcam). 
Following three washes with TBST, the samples were stained according to the manual of 
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EnVision ® + System-HRP Labelled Polymer Anti-Rabbit (K4011, Dako). Thereafter the 
sample was counterstained with hematoxylin for 7 min, and then rinsed with tap water for 10 
min.  After dehydration with ethanol (70%, 96%, and 100%) and xylol in sequence, the 
samples were mounted with mounting medium (41-4011, Medite) before imaging.  
Preservation of the main extracellular matrix proteins in the portal field and the sinusoidal 
network was assessed by comparing immunohistochemical images from normal and 
decellularized liver samples.  
Silicon rubber compound staining  
To visualize the integrity and patency of the portal vascular tree, 0,5 ml blue silicone rubber 
injection contrast agent (MV120, MICROFIL®, USA) was administered via the left PV in 
normal and decellularized LLLs. About 20 min after injection, the compound polymerized. 
Integrity of the portal tree of the scaffold was judged based on the continuous contrasting of 
vascular tree as well as the detection of intrahepatic leakage. 
Micro-CT scanning  
The scaffold injected with silicone rubber compound was explanted and stored in formalin 
solution at 4 degree for over 48 hours for fixation. For µCT scanning of the scaffold, the liver 
sample was taken out of the fixation solution and placed onto a µCT bed. Then the bed with 
scaffold was put into the µCT machine. A high resolution µCT (SkyScan1272, Bruker, 
Billerica, MA, USA) acquired 940 projections with 2688 x 4032 pixels with 3186 ms 
exposure time, with total duration of 8 hours. The x-ray tube was operated at voltage 60 kV 
and current 0.166 mA with an aluminum filter of 0.25 mm thickness. After scanning, a 
volumetric stack with voxel size 6.6 µm was constructed by filtered backprojection. The 
images were used for 3D-reconstrution of the portal tree  using the software IMALYTICS 
Preclinical 2.0 [42]. 
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To assess the structural integrity of the portal tree, we determined the continuity of the 
vascular tree after 3D-reconstruction and the level of branching. 
Scanning electron microscopy  
To evaluate the three-dimensional ultrastructure of the decellularized scaffold, scanning 
electron microscopy was conducted. A normal and a decellularized LLL were subjected to 
perfusion fixation with 20 ml of a mixture of 4% paraformaldehyde, 2.5% glutaraldehyde and 
0.1 M cacodylate buffer (pH 7.4). After perfusion, the LLL was excised and placed into the 
fixative for 24h at room temperature. Afterwards the samples were washed three times for 10 
minutes each with cacodylate buffer and dehydrated in ascending ethanol concentrations (30, 
50, 70, 90 and 100%) for 10 minutes each. Subsequently, the samples were critical-point dried 
using liquid CO2 and sputter coated with gold (thickness approx. 4 nm) using a SCD005 
sputter coater (BAL-TEC, Liechtenstein) to avoid surface charging. Finally the specimens 
were investigated with a field emission (FE) SEM LEO-1530 Gemini (Carl Zeiss NTS 
GmbH, Oberkochen, Germany. 
Images were taken at different magnifications. Similar to the histological investigation we 
focused on determining the integrity of the ultrastructure of the matrix in the portal triad and 
of the CV. We also assessed the integrity of the ultrastructure of the sinusoidal matrix 
network.  
DNA quantification 
To further assess the complete removal of cells in the decellularized scaffold, DNA 
quantification was carried out. DNA was extracted from a small piece (up to 25mg) of excised 
normal liver and the decellularized scaffolds using QIAamp DNA Mini Kit (QIAGEN) 
according to the instruction of QIAamp DNA Mini and Blood Mini Handbook (2016, 
QIAGEN). DNA-concentration was measured by Spectrophotometry using a Nanodrop1000.  
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Statistical Analysis 
All results are presented as mean ± standard deviation. Statistical comparisons were made 
through the use of a Student's t-test performed within SPSS Statistics 25. Statistical 
significance was determined to be p < 0.05. 
 
Results  
Selective perfusion of the left lateral lobe using the modified method 
After perfusion of the LLL with heparinized saline, the lobe did gradually change the color 
from red to faint yellow (Fig 4A-B), indicating that the blood in the portal system of the lobe 
was completely washed out. However, as reported before, clamping of the left lateral PV 
caused ischemia of the left median lobe (Fig 4B). The histological assessment of the lobe 
further confirmed that no blood cells were visible in the PV branches and CVs, compared to a 
native liver lobe (Fig 4C-F). This indicates that the modified in-vivo circuit bypass also 
enabled the selective perfusion of the LLL without causing any further damage. 
Identification of the optimal decellularization protocol for in-vivo perfusion 
decellularization 
Using 1% Triton X100 followed by 1% SDS within 2 hours resulted in incomplete removal 
of the cellular components of the liver lobe as indicated by non-translucent areas of different 
size (Fig. 5A-D). Histology revealed large areas of cell-free parenchyma interspersed with 
islands of remaining cells, confirming the incomplete decellularization result (Fig. 6B). 
Correspondingly, the DNA concentration after random sampling of the liver was as high as 
1366.92± 500.89 ng/mg (n= 6/6, wet tissue), which is about 50% of the normal liver 
(3091.31± 192.89 ng/mg, n=6/6) (P < 0.0001). 
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Perfusion with 1% TritonX100 alone did not result in decellularization but caused a smooth 
change in color from faint yellow to a non-translucent white appearance of the LLL within 2 h 
(Fig. 5E-H). Similarly histology showed that hepatic parenchyma was not removed. However, 
detergent perfusion caused the loss of nuclear stain in the majority of the liver cells, 
suggesting at least severe damage or death of the cells. Interestingly a small rim of seemingly 
vital cells was seen in the vicinity of the portal field. In between the hepatic chords large 
empty spaces became visible suggesting the removal of at least some hepatocytes (Fig. 6C). 
These finding were confirmed by the DNA-concentration measurement revealing slightly 
lower levels (2614.94±547.73 ng/mg, n=6/6) (P=0.16 > 0.01) than in the normal liver.  
In contrast, perfusion with 1% SDS alone gradually cleared the liver from all cellular 
components within 2 h as indicated by the translucent appearance (Fig. 5I-L). No areas with 
remaining cells or cellular debris were detected in any of the histological sections (Fig. 6D). 
Correspondingly, the remnant DNA concentration was as low as 57.40±11.71 ng/mg, which 
represents less than 2% of the DNA-concentration of normal liver lobe (P< 0.00001) (Fig.7). 
Taken together, these findings suggest that in-vivo decellularization with 1% SDS only for 2 
h is very effective compared to the other two protocols and was therefore used in the 
subsequent experiments.  
Characterization of the scaffolds generated with the optimal decellularization protocol 
(1%SDS) 
First we characterized the vascular tree of the scaffold generated with the optimal 
decellularization protocol based on macroscopic evaluation. The vascular trees including the 
PV tree system and HV system (Fig. 8A) are macroscopically visible in the translucent matrix. 
The blue silicon rubber compound solution injected through the left PV appeared as expected 
inside the portal vascular network. Upon injection, it gradually moved from the lobar portal 
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vein vessels to smaller venules, indicating the integrity of the portal vascular structure (Fig. 
8B). Since injection was stopped when the blue compound reached the finest branches of the 
portal vascular tree, the hepatic venous tree appeared white in the otherwise translucent 
scaffold (Fig. 8B).   
We further visualized the portal vascular tree in three dimensions by Micro-CT scanning and 
3D reconstruction. CT scanning confirmed that the continuity of portal vascular tree was 
clearly visible upon 3D reconstruction. Furthermore, the large sized lobar portal vessels up to 
the forth to fifth order (Fig. 8D) remained intact, which is comparable to the normal LLL.  
Second, histological staining of the scaffold showed key features of the hepatic acinus. Portal 
fields could be clearly identified based on remaining matrix structure of PV, HA and BD. CVs 
appeared as single vascular matrix structures. In addition, the decellularized hepatic lobules 
appeared as dense network of sinusoidal structures resembling a spider net (Fig.6D). These 
findings suggest that hepatic microarchitecture was morphologically preserved after in-vivo 
decellularization of the selected liver lobe. 
Third, the scanning electron microscopy images revealed the integrity of the ultra- structure 
of the matrix including the PV, HA, BD (Fig.8F) and the CV (Fig.8G). We observed the 
continuous sinusoidal matrix network in the parenchyma of the scaffold (Fig.8F-G). These 
findings show the integrity of the ultravascular structure in the decellularized liver scaffold, 
compared to native liver lobe. 
As the forth and last step, using a staining panel consisting of histochemical and 
immunohistochemical methods, the protein components of the scaffold were assessed.  
Using the EVG-staining, we observed strong red signals (collagen) in the portal field (Fig.9 
A-B) and around the CV (Fig.9 C-D) of the scaffold, similar as in the native liver. Compared 
to the portal field, the staining intensity in the sinusoidal matrix network was much weaker, 
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indicative of the different collagen content in the structures. In the scaffold, we did neither 
observe any black nuclear signals, nor any yellowish cytoplasmic stain, indicating the 
removal of cells or cell remnants.  As expected, we saw only a faint dark purple signal in the 
HA of the native liver but not clearly in the scaffold.    
This was further confirmed by the Collagen IV-staining. We observed an over-all stronger 
signal in both the native liver and the decellularized scaffold. The strong signal in the portal 
field, especially in the basal membranes, facilitated the identification and differentiation of the 
three key structures PV, HA and BD (Fig.9 E-F). Due to the strong staining of the basal 
membrane also the CV (Fig.9 G-H) could be detected easily. Furthermore, the strong staining 
of the sinusoidal network can be taken as indicator of the preservation of the sinusoidal 
matrix.  
The immunohistochemical signal for Laminin, normally expressed in the basal membrane of 
vessels and to a much lesser extent also in the sinusoids, was strong in the portal field (Fig.9 
I-J) and in the CV (Fig.9 K-L).  In contrast, the signal was rather weak in the sinusoidal 
network, also reflecting the preservation of the physiological distribution of the ECM-protein.  
Fibronectin is one of the most abundant proteins in the perisinusoidal space surrounding the 
periportal and CV regions [43]. We observed a strong signal in the portal field (Fig.9 M-N) 
and around the CV (Fig.9 O-P) of the native liver, which was less pronounced in the scaffold. 
Similarly, we observed a slightly weaker signal in the sinusoidal matrix of the scaffold 
compared to the native liver. This gives rise to the speculation, that the detergent might have 
affected the fibronectin content of the scaffold.  
Elastin is mainly expressed in the vasculature of normal liver as indicated by strong brown 
signals but less in the sinusoids, as visualized by light brown signals (Fig.9 Q and S). In the 
LLL scaffold, strong signal intensity was seen in the portal field (Fig.9 R) and in the CV 
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(Fig.9 T), which is similar to the pattern observed in normal liver. Similarly, the staining 
intensity was much fainter in the sinusoidal network, both suggesting preservation of this 
ECM-protein as well.  
Identification of the optimal organ protection during in-vivo decellularization (1%SDS)  
During in-vivo perfusion decellularization, waste fluid emerged from the incision hole in the 
left lateral HV but also from the surface of the liver (Fig.10), in total about 200 ml within the 
2 h procedure. To protect the abdominal cavity and all organs completely from this volume, 
placement of the PVDC film covered by gauzes was insufficient to absorb and drain this large 
amount of corrosive waste fluid. Animals subjected to this procedure died within 48 hours 
(n=5/6) and just only one (n=1/6) survived for at less one week. Only after placing an 
additional suction tube between the gauze layers, complete prevention of contamination was 
achieved. All animals (n=6/6) subjected to the drainage method of PVDC film + dry gauze + 
suction tube tolerated the procedure well as indicated by the survival rate of 100% after the 7 
d observation time. In contrast in the group of rats subjected to the simple procedure (no 
suction tube), only 16.7% (1/6) reached the end of the observation period, as shown in the 
Kaplan-Meier curve (Fig.11). None of the rats subjected to the combination of PVDC film + 
dry gauze + suction tube suffered from any severe postoperative complications. The maximal 
body weight loss during the first 7 post-op days was less than 20% and occurred on 
postoperative day 2-3, and with a fast recovery thereafter (Fig.12). This observation suggests 
that the procedure was well tolerated and that did not experience severe toxic SDS-related 
side effects.   
Physiological reperfusion of the decellularized scaffold in-vivo 
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After closing the incision on the left PV and the left lateral HV and reopening the blocked left 
PV, artery and BD to the left lateral scaffold, the color of the scaffold changed back from 
translucent (Fig.13A) into red (Fig.13C), suggesting blood reperfusion of the scaffold.  
Histology obtained 12 h after reperfusion revealed large amounts of erythrocytes in PV, 
sinusoidal network and CV, albeit distributed very inhomogeneously throughout the section. 
In all 3 animals we also found blood clots in large intralobar vessels leading to a partial 
blockade of the vessel (Fig.13D-E).   Furthermore, in one of the 3 animals we observed an 
alteration of erythrocytes and formation of hemoglobin crystals in some areas of the section 
(Fig.13F).   
 
Discussions 
In this study we demonstrate for the first time long-time survival after in-vivo liver lobe 
decellularization and physiological reperfusion in rats. Furthermore, our technique resulted in 
remarkable scaffold quality.  
Decellularization time  
In comparison to the first report of in vivo decellularization by Pan [27], our procedure took 
longer with 2 h compared to 1 h reported by them. This might be related to the size of the 
targeted liver lobe with the LLL being 5-fold the size of the right superior liver lobe,  
according to the rat liver volume measurement reported by Madrahimov [43]. Nevertheless, 
completing the operation including laparotomy, decellularization and closure within 3 h still 
allows using up to 90 min for reseeding the organ in-vivo to keep the total time below 5 h. 
Our previous study investigating in-vivo perfusion of the LLL revealed that an operation time 
of less than 5 hours was still tolerated by the animals. However, when prolonging the time to 
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5 hours or more, the  rats developed transient diarrhea and bloody ocular discharge [25]. In 
contrast, Pan needed about 2 hours for in-vivo decellularization and reseeding, but sacrificed 
the rats intraoperatively after additional 6 h of observation without even attempting to assess 
the survival rate and time.  
Using 1% SDS for in-vivo liver lobe decellularization resulted in a complete removal of cells 
in the targeted liver lobe within 2 h, which is even more time-efficient than using Triton X100 
alone or the sequential application of Triton X and SDS in our study. Additionally, loss and 
destruction of matrix protein might be related to the exposure time to the harsh detergents, as 
shown in detail for porcine aorta by Guler [44]. Therefore, it is critical to reduce the exposure 
time for the sake of preserving more matrix proteins. Using only 2 hours of 1% SDS-
perfusion for in-vivo decellularization is substantially shorter compared to the duration of ex-
vivo decellularization ranging from hours to days or even weeks reported by other authors 
mentioned above. The reason why we could shorten the decellularization time may be due to 
an extensive heparin saline flush of the live lobe prior to decellularization. Using heparin did 
not only help to prevent disseminated intravascular coagulation but also dissolved small 
thrombi formed in the vessel after clamping. Such microthrombi causing obstruction may 
hinder the flow of the detergent into the liver lobe and slow down the process of 
decellularization. 
Decellularized scaffold quality  
Our work suggests that in-vivo selective liver lobe decellularization did create a translucent 
liver matrix while preserving the integrity of the matrix structure. PV, HA, BD and CV, as 
well as the ultrastructure of the matrix were confirmed by CT, histology and SEM. The main 
matrix proteins including laminin, elastin, fibronectin and collagen IV were preserved as 
indicated by the presence of strong signals in immunohistochemistry. Therefore, we could 
apparently identify and discriminate all vascular structures in the portal field and visualized 
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the continuous sinusoidal network using standard immunohistochemical staining. We provide 
the first data of a very detailed description of the fine structures of in-vivo decellularized liver 
lobe scaffolds in contrast to other reports, which just claimed their structural integrity based 
on a global assessment [16, 24, 35, 45]. 
SDS contamination and toxicity 
Since long term survival is the prerequisite for establishing in-vivo liver engineering 
successfully, this was the reason why we solved the drainage problem first before focusing on 
scaffold repopulation. Detergent waste fluid emerged not only from the incision in left lateral 
HV, but also from the whole surface of the targeted liver lobe during in-vivo perfusion 
decellularization process. Therefore, the whole abdominal cavity and all abdominal organs 
were at risk of contamination with the detergent. Pan and co-workers [27] already identified 
the risk of contamination, but only used a catheter placed in the outlet created in the inferior 
vena cava (IVC). This catheter can effectively drain a substantial amount of the waste fluid, 
however cannot prevent contamination with waste fluid emerging from the surface of the liver 
lobe undergoing decellularization.   
We efficiently prevented the outflowing detergent waste fluid from contaminating non-
targeted tissue and organs in the abdominal cavity by covering them with PVDC film. PVDC 
film is widely used for wrapping food [46, 47] because it is insoluble in oil and organic 
solvents. It has a very low moisture regain and is impervious to mold and bacteria. PVDC 
seems to act as a remarkable barrier not only against water, oxygen, and aromas but also 
against base and acid solutions. Besides using the mechanical PVDC barrier, we efficiently 
drained the waste fluid using dry gauze as well as an aspiration tube. Reduction of 
contamination by using an aspiration tube in addition to the PVDC-film and dry gauze 
seemed to be most decisive for the survival of the animals.    
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Furthermore, we did not only perfuse the decellularized scaffold with warm saline solution, 
but also flushed the abdominal cavity with warm saline solution after decellularization to 
wash away the residual SDS.  
Thereby, all these measures together enabled the long term survival of the animals without 
experiencing severe toxic side effects. Additionally, the maximal postoperative body weight 
loss never exceeded 20% and recovered from postoperative day 3 onwards.  Based on our 
observations we concluded that using the combination of PVDC film + dry gauze + aspiration 
tube as drainage method together with a though perfusion of the scaffold and a wash of the 
scaffold and the abdominal cavity resulted in an efficient prevention of a potential 
contamination with residual SDS. Therefore, we did not go deeper in the exploration of 
potential systemic toxic effects of the SDS. 
Limitations 
Despite of anatomical and technical challenges, we successfully established a survival model 
of in-vivo selective liver lobe decellularization rat. However, there are also some limitations: 
First, since the left PV supplies the left lateral PV and the left lateral PV, transient ischemia of 
the left median lobe (only representing approx.15% of the whole liver in volume) is inevitable 
due to blockage of the left PV. Transient ischemia might induce some liver damage, but is not 
putting the animal at a vital risk.  
Furthermore, other rarely used detergents like deoxyribonuclease (DNase)  [48, 49], sodium 
lauryl ether sulfate (SLES) [48] and sodium deoxycholate (NaDOC) [50], possibly resulting 
in an even shorter time for in-vivo decellularization were not included in the comparison of 
the decellularization protocols.  
Finally, the “naked” collagen of the scaffold can activate the extrinsic coagulation system 
upon contact with blood upon reperfusion. Therefore, it is not surprising that we observed 
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blood clots in the scaffold similar as also reported by others [23, 26, 27].  This might explain 
the very inhomogeneous distribution of blood cells within the scaffold. Another interesting 
finding was the observation of altered swollen erythrocytes and the formation of crystals 
which were also distributed inhomogeneously throughout the scaffold. Both together, swollen 
erythrocytes potentially undergoing hemolysis and releasing hemoglobin in direct 
neighborhood to crystals lead to the suspicion that hemoglobin crystals did form. Hemoglobin 
crystal formation was observed previously, in the brain of rats with experimental intracerebral 
hemorrhage [51], in lungs with pulmonary hemorrhage of varying etiologies [52-54], but also 
as a result of pressure injury to rat dentition [55]. In our case, hemoglobin crystal formation 
might be due to toxic injury because of minimal residual SDS trapped in the protein structure 
of the scaffold leading to hemolysis with subsequent release of hemoglobin. Assuming a 
volume of the LLL of approximately 3 ml, we perfused the lobe with 50 ml saline solution, 
17-fold higher volume which should lead to substantial reduction of remaining SDS. However, 
it cannot be excluded that even low levels of SDS binding to the scaffold proteins might cause 
local hemolysis with subsequent crystal formation.  
Furthermore, it is highly likely that the loss of cells reduces the stability of the resulting 
scaffold rendering the scaffold very prone to perfusion inhomogeneities. Inhomogeneous 
perfusion may result in an incomplete wash and a highly variable distribution of blood 
reperfusion resulting in locally different levels of residual SDS as indicated by an 
inhomogeneous distribution of hemoglobin crystals.  
Perspective 
Both observations of clot formation and haemoglobin crystallization call for a kinetic 
observation of the reperfusion process over time to investigate the reperfusion quality of the 
scaffold and the effectivity of the wash-out procedure. For excluding any potential local and 
systemic toxicity of residual SDS,  a number of tests could be performed at different 
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observation time points during the first postoperative week such as (1) a detailed histologic 
work-up of the scaffold to better understand the timing of blood clot and crystal formation,  (2) 
blood count to detect any eventual hemolysis, (3) determination of local SDS-scaffold and 
systemic SDS-blood levels as direct evidences of SDS contamination, histology of other 
organs e.g. heart, lung, kidney, spleen and undecellularized liver lobes,  as well as (4) clinical 
chemistry including liver function and renal function to identify any organ-specific effect. 
Since blood clots were observed in the blood reperfused scaffold, we believe that the next 
urgent problem to address is to prevent coagulation in the scaffold for ensuring in-vivo 
physiological perfusion. It is highly unlikely that reseeding the scaffold with endothelial cells 
with a very short time for cell adherence is sufficient to prevent clotting. Recently one 
interesting technique was suggested by Bruinsma [56] for preventing coagulation when 
transplanting a repopulated liver scaffold. They reported applying a layer-by-layer heparin 
coating technique to a scaffold before reseeding the scaffold in-vitro prevented coagulation.  
Once anticoagulation in-vivo is achieved, we will pursue in-vivo liver reengineering by in-
vivo recellularization of the liver scaffold with hepatocytes and non-parenchymal cells, as 
done ex-vivo by other authors [23, 24, 56-59].   
For fundamental research, the key benefit of in-vivo partial liver decellularization is its 
potential for promoting the understanding of liver engineering by in-vivo repopulation of a 
liver scaffold. 
Clinical applicability is hampered by the difference in the lobar and vascular anatomy of the 
liver. The human liver represents one large organ which is separated by the underlying 
vasculature in a right and left lobe, but without being separated into two anatomically distinct 
lobes. Therefore creating a bypass circuit is only possible after parenchymal transection as 
performed in the ALPPS-procedure (Associating Liver Partition & Portal Vein Ligation for 
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Staged Hepatectomy) [60]. This is a therapeutic surgical procedure which is currently used to 
enhance resectability for otherwise unresectable liver tumors by ligating the portal vein from 
one liver lobe to promote regeneration of the other partitioned liver lobe. Therefore, in-vivo 
selective lobe perfusion followed by decellularization would be feasible after parenchymal 
transection. In-vivo selective liver lobe decellularization may be an alternative method of 
chemical resection for patients with diseased livers, e.g., lobular liver cancer [25, 27] or 
various hepatic-based metabolic disorders. And then hepatic function could be restored 
through in-vivo repopulation of the decellularized scaffold with healthy liver cells or stem 
cells [27]. In most hepatic metabolic disorders, recovery of only about 10% of the original 
enzyme activity is sufficient to ensure adequate metabolic control [61-62].   
 
Conclusions 
Overall, despite of technical and anatomic challenges, we provide the first data on having 
successfully established a survival model of in-vivo partial liver decellularization in living 
rats, which represents groundwork towards in-vivo organ engineering. 
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Figures and legends 
 
Figure 1.The scheme of identification of an ideal protocol for survival model of in-vivo 
partial liver lobe decellularization in live rat.  
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Figure 2. A. Scheme of modified blockage of the vessels supplying and draining the LLL 
of rat liver. The left PV is blocked with a pair of micro-clamps (lowest black arrow) at the 
base instead of using a suture line. The left HA, the left biliary tract along with the left lateral 
PV, the left lateral HA, and the left lateral BD are blocked with another pair of micro-clamps 
(median black arrow). The left lateral HV is blocked with a pair of micro-clamps (upper black 
arrow) as well. RML: Right median lobe. IVC: Inferior vena cava.  
B. Scheme of modified generation of a selective bypass circulation through the LLL of 
rat liver. The left PV is cannulated with a 24G needle-free catheter as a fluid inlet (yellow 
arrow), and an incision opening (black arrow) is generated as a fluid outlet at the naturally 
exposed region of the front wall of the left lateral HV instead of using a catheter.  
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Figure 3. Intraoperative images showing perfusion system, isolation and drainage for in-
vivo perfusion decellularization. Experimental set up with detergent solution (A1), a display 
(A2) and a peristaltic pump for perfusion (A3). Isolation of targeted LLL from other 
abdominal organs using PVDC film (B) and additional gauze (C) (an inlet catheter, blue 
arrow). Prevention of contamination by placing an additional aspiration tube (D, red arrow) 
between the gauze layer and by connecting  to a suction device.  
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Figure 4. Confirmation of successful selective perfusion of LLL using the modified 
perfusion technique. A. Perfusion catheter (yellow arrow) in place after successfully 
blocking physiological perfusion to LLL as indicated by the dark red color (blue arrow). B. 
Color change of the LLL from dark red into faint yellow (white arrow) after perfusion with 
heparinized saline. Dark red showing the ischemia of the left median lobe (blue arrow). Scale 
bar=1 mm (A-B). C. Presence of blood cells in the PV (purple arrow), HA (red arrow), and 
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CV (E, blue arrow) of the normal liver lobe. D. Absence of blood cells in PV (purple arrow) 
and HA (red arrow) after heparin perfusion of left lateral liver lobe as well as in sinusoids and 
CV (F, blue arrow). Scale bar=250μm (C-F). 
 
Figure 5. Intraoperative images showing in-vivo decellularization of the LLL. Time 
sequence from 5min to 2 hours using 1% Triton X100 followed by 1% SDS resulting in 
incomplete decellularization of the lobe (A-D). And 1% Triton X100 only resulting in colour 
change of the liver lobe (E-H). In contrast, 1% SDS only showing a gradual increasing 
transparency of the LLL (I-L). Scale bar=1 mm (A-L). 
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Figure 6. Histological assessment (HE) of scaffolds comparing three in-vivo 
decellularization protocols. A. Normal liver with blue-black staining nuclei (brown arrow) 
and purplish red staining cytoplasma (blue arrow). Scale bar 250um. B. Liver subjected to 1% 
Triton X100 followed by 1% SDS perfusion resulting in incomplete decellularization with 
cell-free areas (green arrows) but also areas with remnant hepatic parenchyma (brown arrows) 
and cytoplasma (blue arrow). Scale bar 100um. C. Liver subjected to only 1% Triton X100 
perfusion resulting in incomplete decellularization with few cell-free spaces (green arrows) 
and only the changed colour of the  other cells (blue arrows). HA (red arrow). BD (yellow 
arrow). Scale bar 250um. D. Liver subjected to only 1% SDS perfusion resulting in complete 
removal of hepatic cells while preserving collagen (pale pink) leaving the hepatic 
microarchitecture intact. Sinusoidal network (purple arrows). HA (red arrow).BD (yellow 
arrow). Scale bar 50um. 
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Figure 7. Molecular 
assessment of the decellularized scaffolds 
DNA quantification of the decellularized liver scaffolds among the three groups of Triton 
X100 only, Triton X100 followed by SDS and SDS only, in comparison with that of native 
liver lobe.  
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Figure 8. Characterization of structural architecture of the LLL scaffold. (A) Vascular 
trees appearing as white non-translucent structures (black arrows) in translucent scaffold after 
successful decellularization using 1%SDS for 2h. (B) Visualization of portal vascular tree 
(purple arrow) after injecting blue silicone contrast medium leaving the hepatic vascular tree 
uncontrasted (blue arrow). (C) Micro-CT scanning images showing intact portal vascular tree 
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of the decellularized left lateral scaffold comparable to (D) the portal tree of the native LLL. 
(E) SEM demonstrating the ultrastructure of native liver with CV (blue arrow) and cubical 
hepatocytes (green arrows). And (F) the acellular matrix of PV (purple arrow), HA (red 
arrow), BD (yellow arrow) and sinusoidal network (white arrows) presented in the 
decellularized scaffold. (G) Ultrastructure of CV (blue arrow) and hepatocyte-shaped free 
spaces surrounded with sinusoidal network structure (white arrows). Scale bar=1 mm (A-D), 
and 50 µm (E-G).  
 
Figure 9. EvG staining and immunohistochemical assessment of the decellularized 
scaffold demonstrating the preservation of key extracellular matrix proteins in the 
portal field as well as the CV .In normal liver and decellularized liver scaffold and lobe, 
EvG staining showing red collagen (A-D) in the portal field including the PV (PV, purple 
arrows), the HA (red arrow), and the BD (yellow arrow), as well as in the CV (blue arrows) 
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and the sinusoid networks (green arrows). Immunohistological staining of structural matrix 
proteins in normal liver and scaffold demonstrating the preservation of collagen IV (E-H), 
laminin (I-L), fibronectin (M-N), and elastin (Q-T) by the brown signal in the portal fields, 
and the CVs (blue arrows)  as well as in the sinusoidal  networks (green arrows). Scale 
bar=100 µm (A, C, E, M and Q), 50 µm (D, F, K, M, N, O, P and S) and 25 µm (B, G, H, J, 
L, R and T). 
 
Figure 10. 
Intraoperative images showing waste perfusate emerging from the whole surface of the 
LLL during perfusion decellularizaton in-vivo.  
A small square piece of dry gauze placed on the surface of the LLL turning from dry to wet 
within seconds (A-D) during in-vivo perfusion decellularization. Scale bar=1 mm.  
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Figure 11. Survival rate of the rats between two different drainage methods 
Kaplan-meier survival curve of the rats that subjected to the efficient drainage method of 
PVDC film+Dry gauze +suction tube and those that subjected to the less efficient drainage 
method (PVDC film+Dry gauze) during the procedure of in-vivo decellularization. 
 
Figure 12. 
Postoperative body weight   
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A postoperative first-week observation of body weight of the rats subjected to the drainage 
method of PVDC film+Dry gauze +suction tube 
 
Figure 13. Physiological reperfusion of LLL scaffold in-vivo 
(A) In-vivo image of translucent scaffold before and (B) blood filled scaffold immediately 
after reperfusion. Scale bar= 1 mm. 
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(C) HE-Staining of decellularized scaffold before and (D) blood filled scaffold 12h after 
reperfusion. Erythrocytes accumulating in distended large vessels (PV and CV) as well as in 
HA (red arrow), in the compressed sinusoidal network and in the BD (yellow arrow). Blood 
clots (D-E, blue arrows), altered swollen erythrocytes (F, brown arrows) as well as 
hemoglobin crystals (F, green arrows) in some areas of the sinusoidal network and vessels. 
Scale bar= 25 µm (F), 50 µm (B) and 100 µm (D-E). 
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Discussions  
 
Generation of an in-vivo biological scaffold using in-vivo perfusion technique has become a 
promising strategy to study in-vivo liver engineering.  
Our technique is the further development of the technique presented by Pan and offers a 
number of advantages:   
First, preserving of the three main vessels and the bile duct allows physiological blood 
reperfusion as well as bile drainage of a liver lobe scaffold in-vivo. In previous other studies, 
only portal and hepatic vein but not bile duct and hepatic artery were re-anastomosed when 
attempting to transplant an ex-vivo engineered repopulated scaffold [Uygun 2010, Bao 2011, 
Katdota et al 2014, Bruinsma 2015, Ko et al 2015 and Hussein 2016].  In contrast, we 
preserved the left portal vein, left hepatic artery and left lateral central vein, as well as the left 
bile duct of the targeted decellularized liver lobe in-vivo.  This is potentially critical for 
maintaining the viability of cells and the hepatic function after cells repopulation of a scaffold 
in-vivo. 
Second, selecting the left lateral lobe instead of the right lobe enabled to maintain 
physiological perfusion of about 70% of the liver throughout the whole procedure. We did not 
block portal vein and vena cava, thereby preventing portal hypertension and intestinal 
congestion.  
Third, reducing the harshness of the standard detergent protocol by perfusion with 1 % SDS 
only without the use of triton X resulted in a remarkable scaffold quality.  We confirmed the 
results of other studies that SDS alone was of advantage in terms of decellularization time, 
DNA removal and ECM protein preservation [Uygun 2010 and Sullivan 2012]. Although 
SDS can damage ECM, previous studies showed that SDS can not only remove the 
immunogenic cellular components but also better retain the ECM constituents, compared to 
Triton X [Hussein 2013, Park 2013, Kadota 2014, and Hussein 2015].   
Forth, ensuring efficient protection of the abdominal organs was achieved by minimizing 
detergent-induced corrosive injury. We used a PVDC-film to isolate the organs from the 
detergent and placed placing a suction tube in addition to dry gauze to efficiently drain the 
waste fluid.  
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Fifth, completing the whole procedure in less than 3h left approximately 2h for later 
reseeding the scaffold without exceeding the maximally tolerated operation time for about 5h. 
We flushed the liver lobe with heparin saline before in-vivo decellularization to prevent 
disseminated intravascular coagulation but also to dissolve small thrombi formed in the 
vessel, thereby accelerating the process of decellularization.  
Altogether, we confirmed that the procedure of in-vivo selective liver lobe decellularization 
was not only well tolerated by the animals but also resulted in the complete removal of 
cellular components and a remarkably high scaffold quality.  
Thus, we consider having achieved the next step on the road to in-vivo liver engineering, a 
technique very suitable to achieve a better understanding of scaffold repopulation.  
However, there is still a major challenge to overcome: the prevention of coagulation in native 
liver scaffold upon reperfusion with blood. Therefore, we already considered the following 
options to reduce the thrombogenicity of the scaffold: 
Manuscript III in preparation 
1. Reseeding with endothelial cells  
Repopulating the scaffold with endothelial cells is supposed to be capable of preventing 
coagulation. Reseeding the scaffold with endothelial cells can naturally cover the surface of 
collagen inside the scaffold.  Preventing collagen from being exposed to blood platelets and 
coagulation factors is preventing the initiation of the coagulation cascade.  
However, according to our experience the total operation time should not exceed 5 hours. 
Subsequently, the time for reseeding endothelial cells in-vivo including the single or repeated 
application and eventual time for adherence should be limited to maximally additional 2 hours. 
Compared to ex-vivo re-endothelialization which needs several days [Uygun 2010, Ko 2015, 
Hussein 2016 and Devalliere 2018], this time frame is rather short. Furthermore, coverage of 
the vasculature through reseeding endothelial cells may be incomplete and uneven, resulting 
in areas potentially not covered with endothelial cells and remaining thrombogenic. These two 
limitations may result in an incomplete prevention of coagulation.  
2. Systemic heparinization  
Full heparinization is very effective in preventing coagulation. Heparin binds with high 
affinity to the protein antithrombin III, thrombin and coagulation factor Xa. Therefore, it is an 
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ideal bio-active agent for anticoagulation [Werner 2007]. However, to our knowledge, there 
are no reports regarding systemic heparinization for anticoagulation after blood reperfusion of 
a liver scaffold or engineered liver grafts in-vivo. To prevent coagulation efficiently, full 
heparinization would be needed. However, this may cause bleeding from the in- and outlet as 
well as from the base of the liver lobes previously clamped.   
3. Local heparinization 
Recently, local heparinization has been used for anticoagulation through directly flushing the 
decellularized scaffold with heparin. Heparin immobilized in a decellularized bioscaffold acts 
as an antithrombotic coating reagent and binds vascular endothelial growth factor (VEGF) to 
induce angiogenesis in the scaffolds [Kidane 2004, You 2011, Bae 2012 and Wei 2013]. 
3.1 Layer by layer heparin coating technique 
For Layer by layer heparinization technique, the luminal surface (negatively charged) of the 
biological scaffold is covered with positively charged polyelectrolyte followed by a 
negatively charged heparin solution.  This sequence is repeated several times   forming a 
multilayer film adhering together by electrostatic force. This interesting technique was 
already used successfully in some studies to prevent coagulation when transplanting a 
repopulated liver scaffold [Bao 2011, Bao et al 2015, and Bruinsma 2015]. 
3.2 Own experiences:  
Therefore, we did first pilot experiments for preventing coagulation using the layer by layer 
heparin coating technique modified from Bao [Bao 2011]. After in-vivo left lateral lobe 
decellularization, we washed the liver lobe for 10 min with 50 ml 0.9% sodium chloride to 
remove residual 1% SDS. To prevent coagulation, prior to blood reperfusion of the scaffold, 
we perfused the liver scaffold with 5ml polyelectrolyte polydiallyldimethylammonium 
chloride (PDADMAC, 1g/L, Mw=100-200 kDa,), and 5ml 0.9% sodium chloride for rinsing, 
followed by 5ml heparin saline (2g/L) and repeated the three steps for three times.  
Afterwards, we reperfused the scaffold in-vivo with autologous blood by releasing the clamps 
to reopen the vessels. We checked the base of the decellularized liver lobe for bleeding since 
the clamps obviously damaged the parenchymal tissue before closing the abdomen. Minimal 
small bleeding was observed. This small bleeding did stop upon light compression due to the 
physiological initiation of coagulation and allowed long term survival of the animals. This 
was shown after in-vivo selective liver lobe perfusion with saline [Wang 2018] and after in-
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vivo selective liver lobe decellularization as described in manuscript II. However after local 
heparinization all rats (n=6/6) died within 48 hours, as seen in Figure 1, due to bleeding as 
observed upon autopsy. The bleeding site was at the base of the scaffold damaged by the 
micro-clamps used during in-vivo decellularization. Apparently, the minimal bleeding was 
not fully stopped by compression in the absence of coagulation but must have restarted after 
closing the abdomen, finally causing the death of the animal.  
Histological samples taken whenever the animals died allowed us to monitor the interaction of 
blood perfusion and the scaffold itself over time for up to 48hours. We observed three major 
findings: invasion of erythrocytes and formation of hemoglobin crystals as well as neutrophil 
infiltration in both the vessels and sinusoidal network. 
In all samples (Fig. 2A-D) major vessels were full of erythrocytes. However, the amount of 
blood in the sinusoidal network did vary within the scaffold suggesting inhomogeneous 
reperfusion, with a tendency to fewer erythrocytes at the early time point (1h). No blood clots 
were seen suggesting that the layer-by-layer heparinization was successfully preventing the 
initiation of coagulation.  
In contrast, we observed damaged erythrocytes appearing translucent and colorless and often 
with distorted rather rectangular shape. Interestingly, in the majority of samples (Fig. 2C-F), 
we detected long almost translucent crystalloid structures in the blood vessels, but also in the 
sinusoidal network. Some of them appeared yellowish and others more reddish, possibly 
representing crystalloid hemoglobin aggregates. Two arguments are in favor of this 
interpretation: First, Bielawski reported already in 1989, that SDS, even in concentrations as 
low as 0.003 to 0.001% causes hemolysis of a certain number of erythrocytes [Bielawski 
1990]. Furthermore, he showed that resistance of erythrocytes decreases with temperature. 
Rinsing the scaffold for 5 min with 50ml of 0.9% sodium chloride solution might not be 
sufficient to dissociate all SDS bound to the collagen in the scaffold.  Second, formation of 
hemoglobin crystals was reported after toxic lung [Ghio et al. 2000, Paakko et al. 1996 and 
Zachary et al. 2001] and kidney [Madsen et al. 1982] injury. Hemoglobin crystals were also 
observed in the brain of rats, as seen in Fig. 2G-H taken from Kleinig [Kleinig, 2009], after 
inducing intracranial hemorrhage. In our case crystal formation might be due to a similar toxic 
effect of the residual SDS bound to scaffold proteins and not covered by the subsequent layer 
by layer heparinization.  
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Previous experiments obtained after ex-vivo layer by layer heparinization in liver scaffold and 
prior to in-vivo did not reveal this phenomenon [Bao 2011 and Bruinsma 2015].  However, 
scaffolds were rinsed with PBS [Bruinsma 2015 and Devalliere 2018] or antibiotic-containing 
physiological saline [Bao 2011] more extensively for one or several hours prior to 
heparinization, not feasible in our in-vivo situation. Therefore we consider improving the 
SDS-wash-out step by adding proteins to the rinsing solution and by prolonging the rinsing 
step of the scaffold to better remove residual SDS [Devalliere  2018]. 
Furthermore, over time, we observed an increasing amount of white blood cells infiltrating the 
scaffolds (Fig. 2E-F). The relative frequency of neutrophils increased from the expected ratio 
of 1:1000 white blood cells to red blood cells observed at 3h to a dense predominantly 
neutrophilic infiltrate located in between the hemoglobin crystals and the compressed scaffold 
structure. This could be as least partially due to the pro-inflammatory role of hemoglobin 
crystals suggested by Kleinig [Kleinig 2009]. However, this might not be the only reason for 
the inflammatory reaction within the scaffold. 
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Figure  1 
 
Figure 1. Kaplan-Meier survival curve of the rats that underwent layer by layer local heparinization of 
decellularized scaffold followed by in-vivo blood reperfusion. 
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Figure  2 
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Figure 2. Histological assessment (H&E staining) of scaffolds after local layer by layer heparinization 
followed by blood reperfusion. (A-D) Large amounts of erythrocytes were visible in the large vessels of all 
reperfused heparin-treated liver scaffolds and to a variable extent also in the sinusoidal network. (A and C-F) 
Hemoglobin crystals (blue arrows) were observed in almost all scaffolds (1h, 4h, 18h, 36h and 48h), albeit in 
different extent, very little early after reperfusion and more in the later phase.  (E-F) Large amounts of white 
cells infiltrating the parenchymal space (black arrows) along with hemoglobin crystals (blue arrows) were visible 
in the blood reperfused heparin-treated scaffold at postoperative 36 h and 48 h. Hemoglobin crystals looked 
similar to the ones observed  similar to (G-H) hemoglobin crystals (blue arrows) and white cells (black arrows), 
the ones observed in the brain of rats 24 h after intracerebral hemorrhage as described by Kleinig [Kleinig 2009].  
Scale bar 50 μm (C, D and F). Scale bar 100 μm (B, E and G-H). Scale bar 100 μm (A). 
 
Balance between inhibition of coagulation and risk of bleeding 
Taking our observations together, we observed clotting in the scaffold when reperfusing the 
scaffold without preventing coagulation. However, we encountered lethal bleeding when 
using layer-by-layer heparinization. It seems very hard to achieve the delicate balance 
between ensuring efficient anticoagulation within the scaffold and inducing severe bleeding 
from the damaged, previously clamped base of the liver lobe scaffold. Therefore we evaluated 
the use of local hemostatics.  
We first covered the damaged region of the heparin-treated scaffold immediately after 
releasing the clamps with sealant matrix, (Tachosil, Baxter, German) (Fig.3A). However, 
when waiting for a prolonged period of time (10-20min), we could still observe minimal, but 
constant bleeding from the very small uncovered surface of the scaffold base. Complete 
coverage, especially in between the left lateral portal vein and hepatic vein was difficult to 
achieve due to the large size and stiff property of the matrix in respect to the tiny uncovered 
area of the base (<1mm
2
).  
To achieve better coverage, we then tried to apply a liquid fibro sealant (Fig. 3B) (Tisseel, 
Baxter, German), but with similar result of minimal but constant bleeding. As a next step we 
first applied the matrix and the liquid sealant in addition (Fig.3C) which also did not prevent 
bleeding. As a last step we tried to prevent bleeding by completely covering the scaffold 
Tachosil (Fig.3D), however without improving the result.    
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Figure  3 
 
Figure 3. Intraoperative images showing in-vivo coagulation using hemostatics after local heparinization 
followed by blood reperfusion of the left lateral lobe scaffold. A. Applying solid sealant matrix (green arrow), 
onto the damaged region of the heparin-treated scaffold immediately after releasing the clamp from the hepatic 
artery.  B. Putting a liquid fibro sealant (blue arrow) instead of solid sealant matrix to the bleeding scaffold. C.  
Applying both solid sealant matrix (green arrow) and liquid fibro sealant (blue arrow) onto the scaffold. D. 
Covering the whole surface of the liver scaffold with solid sealant matrix (green arrow). Scale bar=1 mm (A-D). 
 
Other authors used the layer by layer heparin coating technique after ex-vivo liver 
decellularization. They reported efficient prevention of coagulation, but no bleeding problems 
within the observation time of up to 72h [Bao 2011, Bao et al 2015 and Bruinsma 2015].  
However, they only applied the heparin into a scaffold without injury. In contrast, in-vivo 
selective liver lobe decellularization leads to a small but unavoidable relevant parenchymal 
damage at the base of the decellularized liver lobe by the clamps used.  
Therefore we must conclude that local heparinization was not only effectively preventing 
coagulation within the scaffold, but resulted in lethal bleeding at the damaged base of the 
scaffold. Furthermore, using sealant matrix or liquid fibro sealant or both did not efficiently 
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stop bleeding from the physiologically reperfused scaffold and also did not prolong the life 
span of the animals. Thus these findings call for evaluating other methods potentially 
preventing coagulation in the scaffold without increasing the risk of bleeding at the base of 
the scaffold. 
3.3 Heparin-gelatin mixture coating technique 
In a previous study, heparin-gelatin mixture coating of decellularized pig liver scaffold via 
portal vein and hepatic artery ex-vivo did decrease thrombogenicity confirmed by contrast 
angiography after the scaffold was subjected to ex-vivo blood perfusion. It also increased 
migration and attachment of endothelial cells to the vessel wall after re-endothelialization ex-
vivo. However, it took as long as 2 hours for infusion of heparin-gelatin mixture and 
incubation [Hussein 2016]. 
Therefore we are going to try this as next step with or without adding local hemostastics. If 
this would solve the problem, this would call for applying the cells together with the local 
anticoagulative treatment to achieve repopulation. 
 
 
Conclusion 
In brief, we established a surgical perfusion model of selective left lateral liver lobe in-vivo 
in rat. We also presented a survival model of in-vivo left lateral liver lobe decellularization in 
rat resulting in the complete removal of cellular components, yielding a high quality scaffold 
suitable for the subsequent physiological reperfusion. 
Preliminary experiments were directed towards achieving the delicate balance between 
preventing coagulation within the scaffold without increasing the risk for bleeding at the base 
of the scaffold.  Therefore, as a next step we will evaluate other local anticoagulation 
strategies such as the heparin-gelatin mixture coating technique.   
Once these two challenges are resolved, we will explore in-vivo recellularization of the liver 
scaffold with hepatocytes and non-parenchymal cells. 
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